<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2098">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05133843</url>
  </required_header>
  <id_info>
    <org_study_id>2021-0125</org_study_id>
    <nct_id>NCT05133843</nct_id>
  </id_info>
  <brief_title>Complete Functional Assessment of Intermediate Coronary Artery Stenosis Before and After Transcatheter Aortic Valve Implantation (TAVI) in Patients With Severe Symptomatic Aortic Valve Stenosis</brief_title>
  <acronym>CHOICE-FR</acronym>
  <official_title>Complete Functional Assessment of Intermediate Coronary Artery Stenosis Before and After Transcatheter Aortic Valve Implantation (TAVI) in Patients With Severe Symptomatic Aortic Valve Stenosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Leipzig Heart Institute GmbH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Heart Center Leipzig - University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Leipzig Heart Institute GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the current study is to assess complete coronary physiology (FFR, RFR, CFR,&#xD;
      IMR, and CT-FFR) in TAVI candidates with intermediate coronary artery stenosis before and 6&#xD;
      months after TAVI. This aims to determine how TAVI affects coronary blood flow and coronary&#xD;
      microcirculatory function after longer-term follow-up, and how these effects influence FFR&#xD;
      and RFR values. In addition, we aim to correlate invasive functional testing (FFR and RFR)&#xD;
      with non-invasive CT-FFR before and 6 months after TAVI.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, single center, open-label study to&#xD;
&#xD;
        1. compare coronary flow reserve (CFR), index of microvascular resistance (IMR), fractional&#xD;
           flow reserve (FFR) and resting full cycle ratio (RFR) values before TAVI and 6 months&#xD;
           after TAVI&#xD;
&#xD;
        2. correlate testing of microcirculatory function (IMR) with measurements of functional&#xD;
           testing (FFR and RFR) before and six months after TAVI&#xD;
&#xD;
        3. correlate functional testing (FFR and RFR) with computed tomography (CT) derived&#xD;
           fractional flow reserve (CT-FFR) before and six months after TAVI.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 29, 2021</start_date>
  <completion_date type="Anticipated">March 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Prospective, single center, open-label</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of CFR, IMR, FFR and RFR values before TAVI and 6 months after TAVI</measure>
    <time_frame>6 Months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diagnostic accuracy by considering FFR values of &gt;0.80 as normal</measure>
    <time_frame>6 Months</time_frame>
    <description>diagnostic accuracy (sensitivity, specificity, positive predictive value [PPV] and negative predictive value [NPV]) of CT-FFR for the detection of significant coronary stenosis before and 6 months after TAVI by considering FFR values of &gt;0.80 as normal</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diagnostic accuracy by considering RFR values of &gt;0.89 as normal</measure>
    <time_frame>6 Months</time_frame>
    <description>diagnostic accuracy (sensitivity, specificity, positive predictive value [PPV] and negative predictive value [NPV]) of CT-FFR for the detection of significant coronary stenosis before and 6 months after TAVI by considering RFR values of &gt;0.89 as normal</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Coronary Artery Stenosis</condition>
  <condition>Transcatheter Aortic Valve Implantation</condition>
  <arm_group>
    <arm_group_label>Coronary physiology</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Assession of complete coronary physiology in TAVI candidates with intermediate coronary artery stenosis before and 6 months after TAVI.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Assession of complete coronary physiology</intervention_name>
    <description>Assession of complete coronary physiology in TAVI candidates with intermediate coronary artery stenosis before and 6 months after TAVI.</description>
    <arm_group_label>Coronary physiology</arm_group_label>
    <other_name>FFR, RFR, CFR, IMR, and CT-FFR</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt;18 years&#xD;
&#xD;
          -  Willing to participate and able to understand, read and sign the informed consent&#xD;
             document before the planned procedure&#xD;
&#xD;
          -  Severe symptomatic aortic stenosis with indication for TAVI according to current&#xD;
             guidelines deemed by the Heart Team&#xD;
&#xD;
          -  Patients who have undergone coronary CT angiography before TAVI in which CAD could not&#xD;
             be ruled out&#xD;
&#xD;
          -  CAD in one or more native major epicardial vessels or their branches by coronary&#xD;
             angiogram with visually assessed coronary stenosis, in which the physiological&#xD;
             severity of the lesion is in question (typically 40-90% diameter stenosis).&#xD;
&#xD;
          -  Eligible for invasive coronary angiography and functional assessment (FFR, RFR, CFR&#xD;
             and IMR)&#xD;
&#xD;
          -  Eligible for coronary CT-angiography and functional assessment (CT-FFR)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients whose CT-angiography was determined to be non-diagnostic/unreadable during&#xD;
             its evaluation&#xD;
&#xD;
          -  Previous coronary artery bypass grafting with patent grafts to the interrogated vessel&#xD;
&#xD;
          -  Patients with severe lesions with a diameter stenosis â‰¥ 90%, flow-limiting lesions, or&#xD;
             a significant left main coronary artery stenosis&#xD;
&#xD;
          -  Critical coronary artery disease deemed by the Heart Team to require immediate&#xD;
             revascularization&#xD;
&#xD;
          -  Contraindication to adenosine (e.g. bronchial asthma)&#xD;
&#xD;
          -  Chronic renal impairment with severe reduction of glomerular filtration rate (eGFR &lt;30&#xD;
             ml/min)&#xD;
&#xD;
          -  Presence of cardiogenic shock&#xD;
&#xD;
          -  Participation in another interventional study involving the left heart or coronary&#xD;
             arteries&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicolas Majunke, Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Heart Center Leipzig at University of Leipzig, Department of Internal Medicine/Cardiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robin Gohmann, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heart Center Leipzig at University of Leipzig, Department of Internal Medicine/Cardiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed Abdel-Wahab, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heart Center Leipzig at University of Leipzig, Department of Internal Medicine/Cardiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nicolas Majunke, Dr.</last_name>
    <phone>+49 341 865 1428</phone>
    <email>nicolas.majunke@medizin.uni-leipzig.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mohamed Abdel-Wahab, Prof. Dr.</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Heart Center Leipzig at University of Leipzig Department of Internal Medicine/Cardiology</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas Majunke, Dr.</last_name>
      <phone>+49 341 865 1428</phone>
      <email>nicolas.majunke@medizin.uni-leipzig.de</email>
    </contact>
    <contact_backup>
      <last_name>Mohamed Abdel-Wahab, Prof. Dr.</last_name>
    </contact_backup>
    <investigator>
      <last_name>Nicolas Majunke, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robin Gohmann, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mohamed Abdel-Wahab, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 12, 2021</study_first_submitted>
  <study_first_submitted_qc>November 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 24, 2021</study_first_posted>
  <last_update_submitted>November 12, 2021</last_update_submitted>
  <last_update_submitted_qc>November 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Coronary Artery Stenosis</keyword>
  <keyword>transcatheter aortic valve implantation</keyword>
  <keyword>coronary physiology</keyword>
  <keyword>coronary blood flow</keyword>
  <keyword>coronary microcirculatory function</keyword>
  <keyword>non-invasive CT-FFR</keyword>
  <keyword>fractional flow reserve</keyword>
  <keyword>resting full cycle ratio</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
    <mesh_term>Coronary Stenosis</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

